Advertisement
Screener

ARVINAS, INC. (ARVN) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

ARVINAS, INC. Cash Flow Breakdown

Cash flow breakdown shows where ARVINAS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $273.80M went out.
  • Fiscal year ended 2025-12-31: from investing, $407.60M came in.
  • Fiscal year ended 2025-12-31: from financing, $91.40M went out.
  • Fiscal year ended 2025-12-31: change in cash, $42.40M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backNew debtNew shares soldNot split outChange in cash
2025-12-31-$273.80M$407.60M-$91.90M-$200.00K$700.00K*$42.40M
2024-12-31-$259.30M$34.70M$0.00-$400.00K$8.30M*-$216.70M
2023-12-31-$347.80M$203.50M$0.00$0.00$374.70M*$230.40M
2022-12-31-$273.50M$242.80M$0.00$4.70M-$26.00M
2021-12-31$559.40M-$1.31B$0.00$18.60M$260.00M*-$475.60M
2020-12-31-$89.70M$164.30M$0.00$0.00$8.30M$496.30M*$579.20M
2019-12-31-$40.60M-$93.10M-$200.00K$0.00$137.69M$2.21M*$6.00M
2018-12-31-$16.12M-$179.67M-$173.89K$2.00M$114.58M$51.65M*-$27.72M
2017-12-31$5.11M$20.87M-$161.36K$0.00$0.00$25.82M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backNew debtNew shares soldNot split outChange in cash
2026-06-30-$48.30M*$54.90M*-$100.00K*
2026-03-31-$69.20M$13.70M-$100.00K-$55.60M
2025-12-31-$30.40M*$145.80M*-$74.10M*-$100.00K*
2025-09-30-$59.10M*$63.50M*$0.00*-$17.80M*
2025-06-30-$95.40M*$128.80M*$0.00*$500.00K*
2025-03-31-$88.90M$69.50M-$100.00K-$19.50M
2024-12-31-$84.10M*$98.90M*$0.00*-$100.00K*$600.00K*
2024-09-30-$128.00M*$50.50M*$0.00*$2.40M*
2024-06-30$50.30M*$13.10M*-$100.00K*$3.50M*
2024-03-31-$97.50M-$127.80M-$200.00K$1.80M*-$223.70M
2023-12-31-$83.10M*-$53.70M*$0.00*$334.80M*
2023-09-30-$84.80M*$70.00M*$0.00*$37.90M*
2023-06-30-$88.70M*$48.60M*$0.00*$500.00K*
2023-03-31-$91.20M$138.60M$0.00$1.50M*$48.90M
2022-12-31-$71.20M*$19.40M*$500.00K*
2022-09-30-$66.60M*$105.80M*$1.20M*
2022-06-30-$78.60M*$109.00M*$500.00K*
2022-03-31-$57.10M$8.60M$2.50M-$46.00M
2021-12-31-$35.70M*-$115.60M*$3.80M*
2021-09-30$681.50M*-$741.10M*$6.70M*$259.90M*
2021-06-30-$47.40M*-$249.10M*$3.60M*
2021-03-31-$39.00M-$207.80M$4.50M-$242.30M
2020-12-31-$28.96M*$56.91M*$0.00*$5.09M*$466.38M*
2020-09-30-$22.38M*$59.28M*$0.00*$577.30K*$29.92M*
2020-06-30-$21.40M*$5.61M*$0.00*$1.28M*
2020-03-31-$16.95M$42.49M$0.00$1.35M$26.90M
2019-12-31-$16.15M*-$95.43M*-$30.39K*$0.00*$137.69M*-$29.02M*
2019-09-30$1.85M*-$31.81M*-$77.67K*$1.38M*$29.45M*
2019-06-30-$13.57M*-$4.23M*-$46.40K*$399.49K*
2019-03-31-$12.73M$38.37M-$45.54K$0.00$25.60M
2018-12-31-$12.25M*-$101.86M*-$44.70K*$0.00*$114.58M*-$3.42M*
2018-09-30-$10.99M*$11.80M*-$48.36K*$0.00*$2.08M*
2018-06-30-$12.18M*-$45.26M*-$38.57K*
2018-03-31$19.30M-$44.34M-$42.26K$55.00M*$29.92M
2017-12-31$28.16M*$339.54K*-$41.48K*$0.00*

Similar stocks

Stock NameCountryMarket CapPE Ratio
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
Evolus, Inc. (EOLS)United States$0.519B-13.32
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85